Article PDF
Avoid common mistakes on your manuscript.
References
IMS National prescription audit™. Use of Meds in the U.S. review of 2010 in http://www.imshealth.com.
Pacini F, Castagna MG, 2012 Approach to and treatment of differentiated thyroid carcinoma. Med Clin N Am 96: 203–221.
Cooper Ds, Doherty GM, Haugen BR, et al, 2009 Revised American thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19: 1167–11214.
Kendall EC, 1983 Landmark article, June 19, 1915. The isolation in crystalline form of the compound containing iodine, which occurs in the thyroid. Its chemical nature and physiologic activity. JAMA 250: 2045–2046.
Lindholm J, Lauberg P, 2011 Hypothyroidism and thyroid substitution: historical aspects. J Thyroid Res 2011: 809341.
Gkotsina M, Michalaki M, Mamali I, et al, 2013 Improved levothyroxine pharmacokinetics after bariatric surgery. Thyroid 23: 414–419.
Wenzel KW, Kirschsieper HE, 1977 Aspects of the absorption of oral L-thyroxine in normal man. Metabolism 26: 1–8.
Perez CL, Araki FS, Graf H, de Carvalho GA, 2013 Serum thyrotropin levels following levothyroxine administration at breakfast. Thyroid 23: 779–784.
Annibale B, Marignani M, Azzoni C, et al, 1997 Atrophic body gastritis: distinct features associated with Helicobacter pylori infection. Helicobacter 2: 57–64.
Yao X, Forte JG, 2003 Cell biology of acid secretion by the parietal cell. Annu Rev Physiol 65: 103–131.
Centanni M, Gargano L, Canettieri G, et al, 2006 Thyroxine in goiter, Helicobacter pilori infection, and chronic gastritis. N Engl J Med 354: 1787–1795.
Sachmechi I, Reich DM, Aninyei M, Wibowo F, Gupta G, Kim PJ, 2007 Effect of proton-pump inhibitors on serum thyroid-stimulating hormone level in euthyroid patients treated with levothyroxine for hypothyroidism. Endocr Pract 13: 345–349.
Pantoflickova DI, Dorta G, Ravic M, Jornod P, Blum AL, 2003 Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors. Aliment Pharmacol Ther. 15:1507–1514.
Rostom A, Murray JA, Kagnoff MF, 2006. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology 131: 1981–2002.
Virili C, Bassotti G, Santaguida MG, et al, 2012 Atypical celiac disease as cause of increased need for thyroxine: a systematic study. J Clin Endocrinol Metab 97: E 419–422.
Hadithi M, de Boer H, Meijer JW, et al, 2007 Coeliac disease in Dutch patients with Hashimoto’s thyroditis and vice versa. World J Gastroenterol 13: 1715–1722.
Muñoz-Torres M, Varsavsky M, Alonso G, 2006 Lactose intolerance revealed by severe resistance to treatment with levothyroxine. Thyroid 16: 1171–1173.
Ladas S, Papanikos J, Arapakis G, 1982 Lactose malabsorption in Greek adults: correlation of small bowel transit time with the severity of lactose intolerance. Gut 23: 968–973.
Eadala P, Waud JP, Matthews SB, Green JT, Campell AK, 2009 Quantifying the ‘hidden’ lactose in drugs used for the treatment of gastrointestinal conditions. Aliment Pharmacol The. 29: 677–687.
Asik M, Gunes F, Binnetoglu E, et al, 2014 Decrease in TSH levels after lactose restriction in Hashimoto’s thyroiditis patients with lactose intolerance. Endocrine 46: 279–284.
Liwampo L, Hershman JM, 2009 Conditions and drugs interfering with thyroxine absorption. Best Pract Res Clin Endocrinol Metab 23: 781–792.
Colucci P, D’Angelo P, Mautone G, Scarsi C, Ducharme MP, 2011 Pharmacokinetic equivalence of a levothyroxine sodium soft capsule manufactured using the new food and drug administration potency guidelines in healthy volunteers under fasting conditions. Ther Drug Monit 33: 355–361.
Benvenga S, Bartolone L, Pappalardo MA, et al, 2008 Altered intestinal absorption of L-thyroxine caused by coffee. Thyroid 18: 293–301.
Benvenga S, Ruggeri RM, Trimarchi F 2012 Thyroid and drugs. In: Monaco F, (ed) Thyroid Diseases. CRC Press, Boca Raton, FL; pp, 482–483.
Csako GI, McGriff NJ, Rotman-Pikielny P, Sarlis NJ, Pucino F, 2001 Exaggerated levothyroxine malabsorption due to calcium carbonate supplementation in gastrointestinal disorders. Ann Pharmacother 35:1578–1583.
Weitzman SP, Ginsburg KC, Carlson HE, 2009 Colesevelam hydrochloride and lanthanum carbonate interfere with the absorption of levothyroxine. Thyroid 19:77–79.
Irving S, Vadiveloo T, Leese GP, 2015 Drugs that interact with levothyroxine: an observational study from the Thyroid Epidemiology, Audit and Research Study (TEARS). Clin Endocrinol 82: 136–141.
Yue CS, Scarsi C, Ducharme MP, 2012 Pharmacokinetics and potential advantages of a new oral solution of levothyroxine vs. other available dosage forms. Arzneimittelforschung 62: 631–636.
Donangelo I, Braunstein GD, 2011 Update on subclinical hyperthyroidism. Am Fam Physician 83:933–938.
Vita R, Saraceno G, Trimarchi F, Benvenga S, 2014 Switching levothyroxine from the tablet to the oral solution formulation corrects the impaired absorption of levothyroxine induced by proton-pump inhibitors. J Clin Endocrinol Metab 99: 4481–4486.
Vita R, Fallahi P, Antonelli A, Benvenga S, 2014 The administration of L-thyroxine as soft gel capsule or liquid solution. Expert Opin Drug Deliv 11: 1103–1111.
Vita R, Benvenga S, 2014 Tablet levothyroxine (L-T4) malabsorption induced by proton pump inhibitor; a problem that was solved by switching to L-T4 in soft gel capsule. Endocr Pract 20: 38–41.
Won CM, 1992 Kinetics of degradation of levothyroxine in aqueous solution and in solid state. Pharmaceut Res 9: 131–137.
Collier JW, Shah RB, Gupta A, Sayeed V, Habib MJ, Khan MA, 2010 Influence of formulation and processing factors on stability of levothyroxine sodium pentahydrate. AAPS PharmSci 11: 818–825.
Bernareggi A, Grata E, Pinorini MT, Conti A, 2013 Oral liquid formulation of Levothyroxine is stable in breakfast beverages and may improve thyroid patient compliance. Pharmaceutics 5: 621–633.
Cappelli C, Pirola I, Gandossi E, Formenti AM, Castellano M, 2014 Oral liquid levothyroxine at breakfast: a mistake? Eur J Endocrinol 170: 95–99.
Zhang H, Zhang J, Streisand JB, 2002 Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications. Clinical Pharmacokinetics 41: 661–680.
Aziz F, Belur R, Albano J, 1979 Malasorption of thyroid hormones after jejunoileal bypass for obesity. Ann Intern Med 90: 941–942.
Bevan JS, Munro JF, 1986 Thyroxine malabsorption following intestinal bypass surgery. Int J Obes 10: 245–246.
Pirola I, Formenti AM, Gandossi E, et al, 2013 Oral liquid L-Thyroxine (L-T4) may be better absorbed compared to L-T4 tablets following bariatric surgery. Obes Surg 23: 1493–1496.
Mendelson AA, Al-Khatib TA, Julien M et al, 2009 Thyroid gland management in total laringectomy: meta-analysis and surgical recommendations. Otolaryng Head Neck 140: 298–305.
Mechanick JI, Brett EM, 2002 Nutrition support of the chronically critically ill patient. Crit Care Clin 18: 597–618.
Mota ML, Barbosa IV, Studart RM, et al, 2010 Evaluation of intensivist-nurses’ knowledge concernine medication administration through nasogastric and enteral tubes. Rev Lat Am Enfermagem 18: 888–894.
Pirola I, Daffini L, Gandossi E, et al, 2014 Comparison between liquid and tablet levothyroxine formulations in patients treated through enteral feeling tube. J Endocrinol Invest 37: 583–587.
Vita R, Saraceno G, Trimarchi F, Benvenga S, 2013 A novel formulation of L-thyroxine (L-T4) reduces the problem of L-T4 malabsorption by coffee observed with traditional tablet formulations. Endocrine 43: 154–160.
Peroni E, Vigone MC, Mora S, et al, 2014 Congenital hypothyroidism treatment in infants: a comparative study between liquid and tablet formulations of levothyroxine. Horm Res Paediatr 81: 50–54.
von Heppe JH, Krude H, L’Allemand D, Schnabel D, Grüters A, 2004 The use of L-T4 as liquid solution improves the praticability and individualized dosage in newborns and infants with congenital hypothyroidism. J Pediatr Endocrinol Metab 17: 967–974.
American Academy of Pediatrics, Rose SR, American Thyroid Association, Brown RS, Lawson Wilkins Pediatric Endocrine Society, 2006 Clinical Report. Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics 117: 2290–2303.
Gruters A, Krude H, 2007 Update on the management of congenital hypothyroidism. Horm Res 68: 107–111.
Cassio A, Monti S, Rizzello A, et al, 2013 Comparison between liquid and tablet formulations of Levothyroxine in the initial treatment of congenital hypothyroidism. J Pediatr 162: 1264–1269.
Negro R, Valcavi R, Agrimi D, Toulis KA, 2014 Levothyroxine liquid solution versus tablet for replecement treatment in hypothyroid patients. Endocr Pract 20: 901–906.
Cappelli C, Pirola I, Daffini L, Gandossi E, Agosti B, Castellano M, 2014 Thyroid hormonal profile in elderly patients treated with two different levothyroxine formulations: a single institute survey. Eur Geriatr Med 5: 382–385.
Canaris GJ, Manowitz NR, Mayor G, Ridgway EC, 2000 The Colorado Thyroid Disease Prevalence Study. Arch Intern Med 160: 526–534.
Parle JV, Franklyn JA, Cross KW, Jones SR, Sheppard MC, 1993 Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment. Br J Gen Pract 43: 107–109.
Biondi B, 2012 Natural history. Diagnosis and management of subclinical thyroid dysfunction. Best Pract Res Clin Endocrinol Metab 26: 431–446.
Collet TH, Gussekloo J, Bauer DC, et al, 2012 Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med 172: 799–809.
Moon JH, Park YJ, Kim TH, et al, 2014 Lower-but-normal serum TSH level is associated with development or progression of cognitive impairment including mild cognitive impairment and dementia in elderly: a result from Korean Longitudinal Study on Health and Aging (KLoSHA). J Clin Endocrinol Metab 99: 424–432.
Giusti M, Mortara L, Machello N, Monti E, Pera G, Marenzana M, 2015 Utility of a liquid formulation of Levo-thyroxine in differentiated thyroid cancer patients. Drug Res (Stuttg) DOI:10.1055/s-0034-1384535.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Formenti, A.M., Daffini, L., Pirola, I. et al. Liquid levothyroxine and its potential use. Hormones 14, 183–189 (2015). https://doi.org/10.14310/horm.2002.1579
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.14310/horm.2002.1579